| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1400094 | 重组抗血管内皮生长因子(VEGF)单抗注射液(贝伐单抗) | bevacizumab | Injection | Biological Products(2) | New Drug Application | 2014-11-17 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2016-08-23 | view |